141 related articles for article (PubMed ID: 16630956)
1. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year).
Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
J Allergy Clin Immunol; 2006 Apr; 117(4):946-8. PubMed ID: 16630956
[No Abstract] [Full Text] [Related]
2. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy: adherence based on timing and monitoring control visits.
Vita D; Caminiti L; Ruggeri P; Pajno GB
Allergy; 2010 May; 65(5):668-9. PubMed ID: 19845569
[No Abstract] [Full Text] [Related]
4. [Desensitization -- at home and without pricks. How effective is sublingual immunotherapy? Interview by Erik Heintz].
Darsow U
MMW Fortschr Med; 2005 Aug; 147(33-34):15. PubMed ID: 16144088
[No Abstract] [Full Text] [Related]
5. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children.
de Bot CM; Moed H
Pediatr Allergy Immunol; 2007 Nov; 18(7):627; author reply 628. PubMed ID: 18001435
[No Abstract] [Full Text] [Related]
6. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra A; Cilia M; Pecora S; Passalacqua G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):313-4. PubMed ID: 17191752
[No Abstract] [Full Text] [Related]
7. Sublingual immunotherapy in the treatment of children.
Pham-Thi N; de Blic J; Scheinmann P
Allergy; 2006; 61 Suppl 81():7-10. PubMed ID: 16792599
[TBL] [Abstract][Full Text] [Related]
8. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
10. The safety of sublingual immunotherapy with one or more allergens in adults.
Lombardi C; Gargioni S; Cottini M; Canonica GW; Passalacqua G
Allergy; 2008 Mar; 63(3):375-6. PubMed ID: 18269680
[No Abstract] [Full Text] [Related]
11. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
14. Sublingual and oral immunotherapy.
Canonica GW; Compalati E; Fumagalli F; Passalacqua G
Immunol Allergy Clin North Am; 2004 Nov; 24(4):685-704, vii. PubMed ID: 15474866
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
16. A bright future for sublingual immunotherapy--contra.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):242-50; discussion 250-2. PubMed ID: 17393746
[TBL] [Abstract][Full Text] [Related]
17. [Allergic rhinitis. This year the pollen count is expected to be high].
Hellmann A
MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
[No Abstract] [Full Text] [Related]
18. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
Canonica GW; Passalacqua G
Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
[TBL] [Abstract][Full Text] [Related]
19. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
Mösges R; Köberlein J; Keppler J
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
[No Abstract] [Full Text] [Related]
20. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms.
Bousquet J
Allergy; 2005 Jan; 60(1):1-3. PubMed ID: 15575923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
